Abdulbaki Kumbasar
Research Subjects
Research Interests
Abdulbaki Kumbasar has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
Ozlem Harmankaya
Internal Medicine Department, Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Saglik Bilimleri University, Istanbul, Turkey
14 shared publications- Hakan Kocoglu
Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey
9 shared publications - Omur Tabak
Department of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, Health Sciences University, 34303 Istanbul, Türkiye
9 shared publications - Yildiz Okuturlar
Acibadem University, school of medicine
9 shared publications - Mehmet Hursitoglu
Department of Internal Medicine, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey
7 shared publications - Hanise Ozkan
Department of Internal Medicine, Kanuni Sultan Suleyman Training and Research Hospital, 34303 Istanbul, Türkiye
6 shared publications
Latest Publications
- Open Access
- 28 January 2026
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 50 (1) , 1-6
Retrospective Evaluation of the Relationship Between Glycated Hemoglobin Levels and Infant Birth Weight in Pregnant Women Diagnosed with Gestational Diabetes Mellitus
Metin üzerindeki kelimelere dokunulmadan, satır sonlarındaki hatalı kaymalar düzeltilerek ve başlıklar kalın yapılarak abstract düzenlenmiştir: Objective: Gestational diabetes mellitus (GDM) is any level of glucose intolerance disorder that begins or is recognized during pregnancy for the first time. Glycated hemoglobin (HbA1c) is used in DM diagnosis, treatment, and follow-up. However, there is insufficient data to make a comparable interpretation for HbA1c in pregnant women with GDM. This study aimed to investigate the differences in HbA1c levels and newborn birth weights between GDM and healthy pregnant women. Methods: A total of 391 pregnant women were enrolled in this study. Of these, 192 were diagnosed with GDM based on the oral glucose tolerance test. Additionally, 199 healthy pregnant women with normal glucose levels were monitored as the control group. Outpatient records of patients were retrospectively scanned. Results: A total of 192 pregnant women with GDM and 199 healthy normoglycemic pregnant women were included in the study. Among all the pregnant women, 320 (81.8%) gave birth via cesarean section (C/S), while 71 (18.2%) had a normal spontaneous vaginal birth. The frequency of C/S was found to be higher in patients diagnosed with GDM ($P < .001$). The mean birth weight of all newborns was calculated as 3127.84 ± 674.17 g. The mean birth weight of infants of mothers with GDM was greater than that of infants of healthy pregnancies ($P < .001$). Newborns with complications in GDM pregnancies had lower birth weights than newborns without complications ($P < .001$). Complications were discovered in 59 (30.7%) of the pregnant women with GDM. Preterm births in GDM pregnancies were found to be statistically significantly lower when compared to normal pregnancies ($P = .01$). No significant correlation was found between the birth weight of newborns and maternal HbA1c ($P > .05$). Conclusion: No direct effect of HbA1c levels was found on the birth weight of newborns or the development of complications in pregnant women with GDM. These findings indicate a need for further research with larger sample sizes of pregnant women. Cite this article as: Dumanlı GY, Tabak Ö, Kumbasar A, Aldıkaçtıoğlu Talmaç M. Retrospective evaluation of the relationship between glycated hemoglobin levels and infant birth weight in pregnant women diagnosed with gestational diabetes mellitus. Cerrahpaşa Med J. 2026, 50, 0099, doi: 10.5152/cjm.2026.25099.
- 28 January 2026
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 50 (1) , 1-6
Open AccessRetrospective Evaluation of the Relationship Between Glycated Hemoglobin Levels and Infant Birth Weight in Pregnant Women Diagnosed with Gestational Diabetes Mellitus
Metin üzerindeki kelimelere dokunulmadan, satır sonlarındaki hatalı kaymalar düzeltilerek ve başlıklar kalın yapılarak abstract düzenlenmiştir: Objective: Gestational diabetes mellitus (GDM) is any level of glucose intolerance disorder that begins or is recognized during pregnancy for the first time. Glycated hemoglobin (HbA1c) is used in DM diagnosis, treatment, and follow-up. However, there is insufficient data to make a comparable interpretation for HbA1c in pregnant women with GDM. This study aimed to investigate the differences in HbA1c levels and newborn birth weights between GDM and healthy pregnant women. Methods: A total of 391 pregnant women were enrolled in this study. Of these, 192 were diagnosed with GDM based on the oral glucose tolerance test. Additionally, 199 healthy pregnant women with normal glucose levels were monitored as the control group. Outpatient records of patients were retrospectively scanned. Results: A total of 192 pregnant women with GDM and 199 healthy normoglycemic pregnant women were included in the study. Among all the pregnant women, 320 (81.8%) gave birth via cesarean section (C/S), while 71 (18.2%) had a normal spontaneous vaginal birth. The frequency of C/S was found to be higher in patients diagnosed with GDM ($P < .001$). The mean birth weight of all newborns was calculated as 3127.84 ± 674.17 g. The mean birth weight of infants of mothers with GDM was greater than that of infants of healthy pregnancies ($P < .001$). Newborns with complications in GDM pregnancies had lower birth weights than newborns without complications ($P < .001$). Complications were discovered in 59 (30.7%) of the pregnant women with GDM. Preterm births in GDM pregnancies were found to be statistically significantly lower when compared to normal pregnancies ($P = .01$). No significant correlation was found between the birth weight of newborns and maternal HbA1c ($P > .05$). Conclusion: No direct effect of HbA1c levels was found on the birth weight of newborns or the development of complications in pregnant women with GDM. These findings indicate a need for further research with larger sample sizes of pregnant women. Cite this article as: Dumanlı GY, Tabak Ö, Kumbasar A, Aldıkaçtıoğlu Talmaç M. Retrospective evaluation of the relationship between glycated hemoglobin levels and infant birth weight in pregnant women diagnosed with gestational diabetes mellitus. Cerrahpaşa Med J. 2026, 50, 0099, doi: 10.5152/cjm.2026.25099.
- Open Access
- 18 December 2023
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 8 (4) , 463-469
Diabetes Management and Problems Experienced by Patients with Type 1 Diabetes Mellitus During the COVID-19 Pandemic: A Qualitative Study
Objective: A study was conducted to obtain information about problems in diabetes management experienced by patients with type 1 diabetes mellitus during the coronavirus disease (COVID-19) pandemic. Materials and Methods: In this qualitative study, in-depth interviews were carried out with 43 patients with type 1 diabetes mellitus (25 women, 18 men) aged 18-34 years who volunteered to participate. Each interview lasted 30 to 35 minutes. The conventional content analysis of data was performed using Graneheim & Lundman method. Results: The mean age of the participants was 26.05±8.01 years, the mean HbA1c level was 9.57±2.57%, and the duration of diabetes was 8.70±5.22 years. The study revealed 7 problem areas related to the patients’ diabetes management during the COVID-19 pandemic: blood glucose control, dietary adherence, insulin dose adjustment, exercising, psychosocial problems, sleep problems, and compliance with COVID-19 preventive measures. Conclusion: The study's results showed that during the COVID-19 pandemic, patients with type 1 diabetes mellitus experienced difficulties in diabetes management and negatively impacted psychosocially.
- 18 December 2023
- Published by Online Turk Saglik Bilimleri Dergisi in Online Türk Sağlık Bilimleri Dergisi
- Vol. 8 (4) , 463-469
Open AccessDiabetes Management and Problems Experienced by Patients with Type 1 Diabetes Mellitus During the COVID-19 Pandemic: A Qualitative Study
Objective: A study was conducted to obtain information about problems in diabetes management experienced by patients with type 1 diabetes mellitus during the coronavirus disease (COVID-19) pandemic. Materials and Methods: In this qualitative study, in-depth interviews were carried out with 43 patients with type 1 diabetes mellitus (25 women, 18 men) aged 18-34 years who volunteered to participate. Each interview lasted 30 to 35 minutes. The conventional content analysis of data was performed using Graneheim & Lundman method. Results: The mean age of the participants was 26.05±8.01 years, the mean HbA1c level was 9.57±2.57%, and the duration of diabetes was 8.70±5.22 years. The study revealed 7 problem areas related to the patients’ diabetes management during the COVID-19 pandemic: blood glucose control, dietary adherence, insulin dose adjustment, exercising, psychosocial problems, sleep problems, and compliance with COVID-19 preventive measures. Conclusion: The study's results showed that during the COVID-19 pandemic, patients with type 1 diabetes mellitus experienced difficulties in diabetes management and negatively impacted psychosocially.
- Open Access
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 605-612
The Relationship between Elevated Plasma Zonulin Levels and Hashimoto's Thyroiditis
By ESRA DEMİR, BURAK ÖNAL, HANİŞE ÖZKAN, et al., Published on 01/01/22
- 1 January 2022
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 52 (3) , 605-612
Open AccessThe Relationship between Elevated Plasma Zonulin Levels and Hashimoto's Thyroiditis
By ESRA DEMİR, BURAK ÖNAL, HANİŞE ÖZKAN, et al., Published on 01/01/22
- 17 December 2021
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 17 (4) , 304-311
Retrospective Evaluation of Hospitalized Patients Treated with Pleural Drainage Due to Pleural Effusion
- 17 December 2021
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 17 (4) , 304-311
Retrospective Evaluation of Hospitalized Patients Treated with Pleural Drainage Due to Pleural Effusion
- Open Access
- 21 September 2021
- Published by Springer Nature in Cureus
- Vol. 13 (9)
Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
Background and aims: Favipiravir is a ribonucleic acid (RNA)-dependent RNA polymerase (RdRP) inhibitor antiviral agent used in the treatment of coronavirus disease-2019 (COVID-19). In this study, we investigated the changes in serum transaminase levels of patients and the relationship between serum transaminase elevation with mortality in patients who were hospitalized with the diagnosis of COVID-19 and received favipiravir treatment. Materials and methods: 454 patients who received favipiravir and 113 patients who did not receive favipiravir were evaluated. Serum transaminase levels of the patients were compared at baseline and after five days of treatment, and the relationship between serum transaminase elevation and mortality was investigated. Results: No significant aspartate aminotransferase (AST) or alanine aminotransferase (ALT) elevation was detected due to favipiravir treatment. AST elevation was found, respectively, as 133 (29.3%), 32 (28.3%) (p=0.100), ALT elevation as 112 (24.7%), 35 (29.3%) (p=0.100) in the groups receiving and not receiving favipiravir. High AST level was found as a risk factor for mortality in all patient groups (p=0.008). Conclusions: There was no statistically significant elevation in serum transaminase levels due to favipiravir use in patients hospitalized for COVID-19. A high level of AST is a significant risk factor to show mortality and intensive care unit (ICU) admission in patients with COVID-19.
- 21 September 2021
- Published by Springer Nature in Cureus
- Vol. 13 (9)
Open AccessElevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19
Background and aims: Favipiravir is a ribonucleic acid (RNA)-dependent RNA polymerase (RdRP) inhibitor antiviral agent used in the treatment of coronavirus disease-2019 (COVID-19). In this study, we investigated the changes in serum transaminase levels of patients and the relationship between serum transaminase elevation with mortality in patients who were hospitalized with the diagnosis of COVID-19 and received favipiravir treatment. Materials and methods: 454 patients who received favipiravir and 113 patients who did not receive favipiravir were evaluated. Serum transaminase levels of the patients were compared at baseline and after five days of treatment, and the relationship between serum transaminase elevation and mortality was investigated. Results: No significant aspartate aminotransferase (AST) or alanine aminotransferase (ALT) elevation was detected due to favipiravir treatment. AST elevation was found, respectively, as 133 (29.3%), 32 (28.3%) (p=0.100), ALT elevation as 112 (24.7%), 35 (29.3%) (p=0.100) in the groups receiving and not receiving favipiravir. High AST level was found as a risk factor for mortality in all patient groups (p=0.008). Conclusions: There was no statistically significant elevation in serum transaminase levels due to favipiravir use in patients hospitalized for COVID-19. A high level of AST is a significant risk factor to show mortality and intensive care unit (ICU) admission in patients with COVID-19.
- Open Access
- 3 September 2021
- Published by The European Research Journal in The European Research Journal
- Vol. 7 (5) , 515-523
The relationship between disease prognosis and serum calcium and corrected calcium levels in COVID-19 patients
Objectives: The present study aimed to evaluate whether low serum calcium (Ca) and corrected calcium (cCa) levels could predict disease prognosis and mortality in patients with COVID-19. Methods: In this study, we retrospectively enrolled 206 eligible patients with COVID-19, diagnosed at Turkey Kanuni Sultan Süleyman Training and Research Hospital between March 12, 2020 and June 15, 2020. Results: Serum Ca level was 8.8 ± 0.57 mg/dL and the serum cCa level was 8.99 ± 0.53 in all patients. The patients were divided into two groups, such as hypocalcemic and non-hypocalcemic patients. We observed that serum Ca levels of patients who died were significantly lower than that of surviving patients. A significant negative correlation was found between serum cCa level and albumin level. A significant positive correlation was found between serum cCa level and C-reactive protein, lactate dehydrogenase, ferritin, procalcitonin, troponin, CURB-65 score, and quick Sepsis-related Organ Failure Assessment (q-SOFA) score. Univariate logistic regression analysis revealed that age, respiratory rate, saturation, heart rate, lymphocyte, serum calcium, D-dimer, CURB-65 score, and q-SOFA score were independent predictors of high-risk group of mortality. Conclusions: This study confirms that the severity of COVID-19 is associated with lower concentrations of serum Ca. The cCa levels were associated with certain prognostic factors. Serum Ca and cCa levels could be an early and helpful marker to improve management of patients with COVID-19. We recommend evaluation of calcium in patients on initial presentation and serial monitoring during hospitalization in order to perform timely and appropriate corrective actions.
- 3 September 2021
- Published by The European Research Journal in The European Research Journal
- Vol. 7 (5) , 515-523
Open AccessThe relationship between disease prognosis and serum calcium and corrected calcium levels in COVID-19 patients
Objectives: The present study aimed to evaluate whether low serum calcium (Ca) and corrected calcium (cCa) levels could predict disease prognosis and mortality in patients with COVID-19. Methods: In this study, we retrospectively enrolled 206 eligible patients with COVID-19, diagnosed at Turkey Kanuni Sultan Süleyman Training and Research Hospital between March 12, 2020 and June 15, 2020. Results: Serum Ca level was 8.8 ± 0.57 mg/dL and the serum cCa level was 8.99 ± 0.53 in all patients. The patients were divided into two groups, such as hypocalcemic and non-hypocalcemic patients. We observed that serum Ca levels of patients who died were significantly lower than that of surviving patients. A significant negative correlation was found between serum cCa level and albumin level. A significant positive correlation was found between serum cCa level and C-reactive protein, lactate dehydrogenase, ferritin, procalcitonin, troponin, CURB-65 score, and quick Sepsis-related Organ Failure Assessment (q-SOFA) score. Univariate logistic regression analysis revealed that age, respiratory rate, saturation, heart rate, lymphocyte, serum calcium, D-dimer, CURB-65 score, and q-SOFA score were independent predictors of high-risk group of mortality. Conclusions: This study confirms that the severity of COVID-19 is associated with lower concentrations of serum Ca. The cCa levels were associated with certain prognostic factors. Serum Ca and cCa levels could be an early and helpful marker to improve management of patients with COVID-19. We recommend evaluation of calcium in patients on initial presentation and serial monitoring during hospitalization in order to perform timely and appropriate corrective actions.
- Open Access
- 1 September 2021
- Published by Kare Publishing in İstanbul Kanuni Sultan Süleyman Tıp dergisi
- Vol. 13 (3) , 236-240
Retrospective Analysis of Colonoscopic Polypectomy Results at University of Health Sciences Turkey Kanuni Sultan Süleyman Training and Research Hospital
- 1 September 2021
- Published by Kare Publishing in İstanbul Kanuni Sultan Süleyman Tıp dergisi
- Vol. 13 (3) , 236-240
Open AccessRetrospective Analysis of Colonoscopic Polypectomy Results at University of Health Sciences Turkey Kanuni Sultan Süleyman Training and Research Hospital
- 1 September 2021
- Published by Kare Publishing in İstanbul Kanuni Sultan Süleyman Tıp dergisi
- Vol. 13 (3) , 227-235
Evaluation of the Clinical Findings and Glycemic Parameters in Patients Newly Diagnosed with Diabetes Mellitus after Being Infected with Coronavirus Disease-2019
- 1 September 2021
- Published by Kare Publishing in İstanbul Kanuni Sultan Süleyman Tıp dergisi
- Vol. 13 (3) , 227-235
Evaluation of the Clinical Findings and Glycemic Parameters in Patients Newly Diagnosed with Diabetes Mellitus after Being Infected with Coronavirus Disease-2019
- Open Access
- 23 March 2021
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Selective Attention and Information Processing Speed in Graves' Disease: Stroop Interference Effect
Background Cognitive functions are affected by thyroid hormones. In this study, we aimed to investigate the selective attention and information processing speed in thyrotoxic Graves' disease. Methodology This study was conducted among 40 patients with thyrotoxic Graves' disease and age and gender-matched 40 healthy controls. Stroop Color and Word test were applied to healthy controls once and to patients with Graves' disease during thyrotoxic and euthyroid periods. Stroop interference effect was calculated. Results The mean age was 34.67 +/- 11 in the Graves' group and 34.72 +/- 9.16 in the control group (p > 0.05). The number of errors and self-corrections in Stroop Color and Word test was higher in patients with thyrotoxic Graves' disease than both patients with euthyroid Graves' disease and healthy controls (p < 0.05). Stroop interference effect was significantly longer in patients with thyrotoxic Graves' disease than both patients with euthyroid Graves' disease and healthy controls (p < 0.05). All parameters obtained from the Stroop Color and Word test including errors, self-corrections, and Stroop interference effect were similar in patients with euthyroid Graves' disease and healthy controls. Conclusions Selective attention was impaired and information processing speed was slow in patients with thyrotoxic Graves' disease, and these findings were associated with age and educational level. After becoming euthyroid through antithyroid medication, these pathological findings returned to normal levels. Additionally, Stroop interference effect was significantly decreased when patients with Graves' disease became euthyroid.
- 23 March 2021
- Published by Springer Nature in Cureus
- Vol. 13 (3)
Open AccessSelective Attention and Information Processing Speed in Graves' Disease: Stroop Interference Effect
Background Cognitive functions are affected by thyroid hormones. In this study, we aimed to investigate the selective attention and information processing speed in thyrotoxic Graves' disease. Methodology This study was conducted among 40 patients with thyrotoxic Graves' disease and age and gender-matched 40 healthy controls. Stroop Color and Word test were applied to healthy controls once and to patients with Graves' disease during thyrotoxic and euthyroid periods. Stroop interference effect was calculated. Results The mean age was 34.67 +/- 11 in the Graves' group and 34.72 +/- 9.16 in the control group (p > 0.05). The number of errors and self-corrections in Stroop Color and Word test was higher in patients with thyrotoxic Graves' disease than both patients with euthyroid Graves' disease and healthy controls (p < 0.05). Stroop interference effect was significantly longer in patients with thyrotoxic Graves' disease than both patients with euthyroid Graves' disease and healthy controls (p < 0.05). All parameters obtained from the Stroop Color and Word test including errors, self-corrections, and Stroop interference effect were similar in patients with euthyroid Graves' disease and healthy controls. Conclusions Selective attention was impaired and information processing speed was slow in patients with thyrotoxic Graves' disease, and these findings were associated with age and educational level. After becoming euthyroid through antithyroid medication, these pathological findings returned to normal levels. Additionally, Stroop interference effect was significantly decreased when patients with Graves' disease became euthyroid.